Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Retained Earnings (2016 - 2025)

Organogenesis Holdings has reported Retained Earnings over the past 10 years, most recently at -$3.1 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$3.1 million for Q4 2025, up 92.33% from a year ago — trailing twelve months through Dec 2025 was -$3.1 million (up 92.33% YoY), and the annual figure for FY2025 was -$3.1 million, up 92.33%.
  • Retained Earnings for Q4 2025 was -$3.1 million at Organogenesis Holdings, up from -$46.8 million in the prior quarter.
  • Over the last five years, Retained Earnings for ORGO hit a ceiling of -$3.1 million in Q4 2025 and a floor of -$140.8 million in Q1 2021.
  • Median Retained Earnings over the past 5 years was -$50.8 million (2022), compared with a mean of -$59.4 million.
  • Biggest five-year swings in Retained Earnings: tumbled 37.97% in 2024 and later soared 92.33% in 2025.
  • Organogenesis Holdings' Retained Earnings stood at -$60.8 million in 2021, then increased by 25.53% to -$45.3 million in 2022, then grew by 9.56% to -$41.0 million in 2023, then grew by 2.1% to -$40.1 million in 2024, then soared by 92.33% to -$3.1 million in 2025.
  • The last three reported values for Retained Earnings were -$3.1 million (Q4 2025), -$46.8 million (Q3 2025), and -$68.3 million (Q2 2025) per Business Quant data.